Home|Journals|Articles by Year Follow on Twitter

Directory for Medical Articles
 

Open Access

Original Research

Int. J. Livest. Res.. 2012; 2(3): 176-182


Validation of energy estimates of mixed diets obtained from RIVGPT through in-vivo digestibility trials in growing ram lambs

Thirumalesh T, Krishnamoorthy U.

Cited by (1)

Abstract
The experiment was conducted in growing ram lambs to validate energy estimates of mixed diets obtained from in vitro incubation for gas production technique (RIVIGPT) through in vivo digestibility trials. Twelve Bannur ram lambs were divided in to four groups of three each. Four mixed diets comprised of rhodes hay (RH) and concentrate supplements (CS) in the ratio of 50:50 were tested in four periods in a switch over design. Each period lasted for four weeks with an adjustment period of three weeks and digestion trial(DT) for one week. The metabolisable energy (ME, MJ kg-1 DM) content of mixed diets at maintenance level of intake obtained by DT for diets-1,2,3 and 4 were 9.3, 8.8, 8.9 and 8.1 respectively. The corresponding ME values obtained from RIVIGP were 9.8, 9.0, 9.3 and 8.7 respectively. The mean ME output (Maintenance + weight gain) for the diets-1,2,3 and 4 were 4.4, 4.2, 4.3 and 4.2 respectively. The ME intake estimated from ME obtained from DT and RIVIGP for the diets-1,2,3 and 4 were 4.5 and 5.0, 4.2 and 4.7, 4.3 and 4.9, 3.9 and 4.6 respectively. Hence, the observed performance of growing ram lambs expressed in terms of the total ME output was accountable to the extent of 98 and 90% of ME intake estimates obtained from ME values derived by DT and RIVIGP respectively.

Key words: RIVIGPT, digestion trial, validation of ME, ram lambs.



Similar Articles

induces innate cytokine responses that potentially provide a protective benefit against COVID-19: A single-arm, double-blind, prospective trial combined with an cytokine response assay.
Kageyama Y, Nishizaki Y, Aida K, Yayama K, Ebisui T, Akiyama T, Nakamura T
Experimental and therapeutic medicine. 2022; 23(1): 20

Re. Identification and Validation of Anaphylaxis Using Electronic Health Data in a Population-based Setting.
Chu PJ, Sheu KL, Wei JC
Epidemiology (Cambridge, Mass.). 2022; 33(1): e2

Slowly digestible property of highly branched α-limit dextrins produced by 4,6-α-glucanotransferase from Streptococcus thermophilus evaluated in vitro and in vivo.
Ryu JJ, Li X, Lee ES, Li D, Lee BH
Carbohydrate polymers. 2022; 275(): 118685

A UHPLC/MS/MS method for the analysis of active and inactive forms of GLP-1 and GIP incretins in human plasma.
Villaño D, Zafrilla P, García-Viguera C, Domínguez-Perles R
Talanta. 2022; 236(): 122806

Bioinformatics analysis and experimental validation of differentially expressed genes in mouse articular chondrocytes treated with IL-1β using microarray data.
Liang F, Peng L, Ma YG, Hu W, Zhang WB, Deng M, Li YM
Experimental and therapeutic medicine. 2022; 23(1): 6


Full-text options


Latest Statistics about COVID-19
• pubstat.org


Add your Article(s) to Indexes
• citeindex.org






Covid-19 Trends and Statistics
ScopeMed.com
CiteIndex.org
CancerLine
FoodsLine
PhytoMedline
Follow ScopeMed on Twitter
Author Tools
eJPort Journal Hosting
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
ScopeMed is a Database Service for Scientific Publications. Copyright ScopeMed Information Services.



ScopeMed Web Sites